Soluble decoy receptor 3: increased levels in atopic patients.

[1]  A. Chiu,et al.  Modulation of Dendritic Cell Differentiation and Maturation by Decoy Receptor 31 , 2002, The Journal of Immunology.

[2]  M. Weller,et al.  Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. , 2001, Cancer research.

[3]  A. Custovic,et al.  Apoptosis signals in atopy and asthma measured with cDNA arrays , 2001, Clinical and experimental immunology.

[4]  C. Akdis,et al.  Cytokine network and dysregulated apoptosis in atopic dermatitis , 2001, Acta odontologica Scandinavica.

[5]  K. Ohshima,et al.  Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas. , 2000, Cancer letters.

[6]  M. Metzker,et al.  Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Otsuki,et al.  Over‐expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients , 2000, Clinical and experimental immunology.

[8]  Jian Ni,et al.  A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis* , 1999, The Journal of Biological Chemistry.

[9]  D. Green.  Apoptosis: Death deceiver , 1998, Nature.

[10]  D. Botstein,et al.  Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer , 1998, Nature.